Description
Vía de administración: Intravenosa (IV) o subcutánea (SC)
PRINCIPIO ACTIVO: EUCALYPTUS
Rituximab 100 mg
un anticuerpo monoclonal que inhibe el factor de crecimiento endotelial vascular (VEGF)
91 G Aerosol Lata
CLENDIX 300MG C 16 VITAMINAB1YB6 Vía de administración: Intravenosa (IV)PRINCIPIO ACTIVO: CLINDAMICINA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
